[The Bell] CUmedical Expands AED Supply to Japan for Fourth Consecutive Year
Predicted impact: Low· Actual: −4.1% vs sector, volume 1.1× normal (5 trading days)
Expanded Japan AED supply for a fourth year; no size given, routine for a tiny company.
CU Medical Systems씨유메디칼
115480 · KOSDAQ · ₩115480 · 씨유메디칼
₩2,010▲ ₩13 (0.65%)End-of-day · Oct 28, 2026 · End-of-day prices.
Price · 1Y −32.55%
- Market cap
- ₩24B
- Enterprise value
- ₩37B
- P/E
- 2.5×
- P/B
- 0.3×
- Dividend yield
- 0.0%
- ROE
- 13.8%
- Net margin
- 15.6%
Trailing 12 months from filed financial statements, as of H1 2026. Dividend yield: the 2025 dividend per share from the annual report ÷ today's price.
52-week range−39.3% from the high
₩1,624Today: ₩2,005 – ₩2,085₩3,310
Returns
- 1W−3.6%
- 1M−12.6%
- 3M+16.9%
- 6M−26.6%
- YTD−26.9%
- 1Y−32.5%
- Volume today
- 13,735
- 1.0× the 20-day average
- Traded today
- ₩28M
- Listed shares
- 12,124,911
- EPS (12 months)
- ₩801
- Earnings yield 39.9%
AI researchResearch being writtenOur AI is writing a report on this company from filed data, prices and news. Check back soon.
Upcoming dates
Full calendar →🎁 Gift this stock
Send a friend ₩100,000 of paper money in this stock. They get it when they join.
Signals
Quiet- BuzzQuietBuzz 44 of 100 (50 is a normal day for this stock).
- MomentumWeak-10.5% over the last month; the price is below its 20-day average.
- News impactLow1 news items and filings in two weeks; 0 rated high impact, 0 medium.
Signals describe activity, not recommendations. Not financial advice.
CU Medical Systems stock overview
CU Medical Systems (씨유메디칼, KRX: 115480) is listed on KOSDAQ, in the Medical & precision devices sector. The company develops, manufactures and sells automated external defibrillators (AEDs), emergency medical devices that deliver a brief electric shock to restore normal heart rhythm, and it was the first in Asia to develop a defibrillator of this kind. Its shares closed at ₩2,010 on Oct 28, 2026, up 0.65% on the day, giving it a market value of ₩24B.
Key facts
- Market cap
- ₩24B
- Sector
- Medical & precision devices
- Latest price change
- +0.65%
- As of
- Oct 28, 2026
- Main business
- The company develops, manufactures and sells automated external defibrillators (AEDs), emergency medical devices that deliver a brief electric shock to restore normal heart rhythm, and it was the first in Asia to develop a defibrillator of this kind.
Quick answers about CU Medical Systems
- What does CU Medical Systems do?
- The company develops, manufactures and sells automated external defibrillators (AEDs), emergency medical devices that deliver a brief electric shock to restore normal heart rhythm, and it was the first in Asia to develop a defibrillator of this kind. Its customers include hospitals, medical institutions, fire stations, public agencies, apartment complexes and businesses, and it sells through direct sales and distributor or dealer networks. Most of its revenue comes from overseas sales in Europe and Japan through local dealers, supported by subsidiaries in Germany and Japan, while its domestic business serves public and private facilities in South Korea.
- What is the market cap of CU Medical Systems?
- The market capitalisation of CU Medical Systems was ₩24B at the close on Oct 28, 2026.
- Who are the largest shareholders of CU Medical Systems?
- According to the latest official filings, the largest reported holders are CU Corporation (30.93%, as of Jul 13, 2026); Sangsangin Savings Bank (12.22%, as of Aug 10, 2026); Bistos (2.54%, as of Mar 17, 2026).
- When is the next earnings report from CU Medical Systems?
- Korean companies rarely announce results dates in advance. Based on when CU Medical Systems filed the same report in past years, its next 3q results is expected around Nov 14, 2026.
Company profile
The company develops, manufactures and sells automated external defibrillators (AEDs), emergency medical devices that deliver a brief electric shock to restore normal heart rhythm, and it was the first in Asia to develop a defibrillator of this kind. Its customers include hospitals, medical institutions, fire stations, public agencies, apartment complexes and businesses, and it sells through direct sales and distributor or dealer networks. Most of its revenue comes from overseas sales in Europe and Japan through local dealers, supported by subsidiaries in Germany and Japan, while its domestic business serves public and private facilities in South Korea.
Written by AI from the company's latest annual report.
- Korean name
- 씨유메디칼
- Themes
- Medical devices
- CEO
- 김형수
- Founded
- Dec 2001
- Listed
- Dec 2011
- Listed shares
- 12,124,911
- Fiscal year ends
- Month 12
- Website
- www.cu911.com
Similar companies
- TSE131290 · ₩3T₩275,000+5.77%
- Kctech281820 · ₩1.9T₩95,500+3.92%
- Classys214150 · ₩1.8T₩27,000+1.89%
- Park Systems140860 · ₩1.6T₩229,500+1.77%
- DI003160 · ₩1.2T₩43,300+14.55%
- LivsMed491000 · ₩1.1T₩43,650+17.65%
- Curiox Biosystems445680 · ₩1.1T₩62,400+0.16%
- Seers458870 · ₩943B₩24,600−6.46%
Recent news
Recent filings
See all- Adjustment of Conversion PriceAug 31, 2026
- Half-year report (Jun 2026)Aug 14, 2026
- 5%+ holding reportAug 10, 2026
- Amended: Annual report (Dec 2025)Jul 24, 2026
- 5%+ holding reportJul 13, 2026
Titles in Korean until English translations are added.
Also known as: CU Medical Systems / 씨유메디칼 / 115480 / KRX:115480
Source: KRX statistical information